CVKD - Company ID 0001937993
Cadrenal Therapeutics, Inc. has filed 237 public company documents between 2022 and 2026. The most frequent type is major company event (50 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 1mo ago2026-05-26 | 2026-05-22 | View filing |
| 144 | Insider sale notice | 2mo ago2026-05-11 | - | View filing |
| 8-K | Major company event | 2mo ago2026-05-07 | 2026-05-07 | View filing |
| 10-Q | Quarterly report | 2mo ago2026-05-07 | 2026-03-31 | View filing |
| 8-K | Major company event | 2mo ago2026-04-30 | 2026-04-30 | View filing |
| EFFECT | EFFECT | 2mo ago2026-04-29 | - | View filing |
| 424B3 | 424B3 | 2mo ago2026-04-29 | - | View filing |
| CORRESP | Company correspondence | 2mo ago2026-04-27 | - | View filing |
| UPLOAD | SEC correspondence | 2mo ago2026-04-27 | - | View filing |
| S-3 | Securities registration | 2mo ago2026-04-21 | - | View filing |
| D | D | 3mo ago2026-04-06 | - | View filing |
| 8-K | Major company event | 3mo ago2026-04-01 | 2026-03-31 | View filing |
| 424B5 | Prospectus supplement | 3mo ago2026-04-01 | - | View filing |
| 10-K | Annual report | 3mo ago2026-03-31 | 2025-12-31 | View filing |
| 8-K | Major company event | 3mo ago2026-03-31 | 2026-03-31 | View filing |
| 8-K | Major company event | 4mo ago2026-03-12 | 2026-03-12 | View filing |
| 8-K | Major company event | 4mo ago2026-02-24 | 2026-02-24 | View filing |
| 424B3 | 424B3 | 6mo ago2026-01-02 | - | View filing |